Does IBANDRONIC ACID Cause Focal segmental glomerulosclerosis? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Focal segmental glomerulosclerosis have been filed in association with IBANDRONIC ACID. This represents 0.2% of all adverse event reports for IBANDRONIC ACID.
7
Reports of Focal segmental glomerulosclerosis with IBANDRONIC ACID
0.2%
of all IBANDRONIC ACID reports
0
Deaths
3
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From IBANDRONIC ACID?
Of the 7 reports, 3 (42.9%) required hospitalization.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IBANDRONIC ACID. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does IBANDRONIC ACID Cause?
Death (578)
Fall (249)
Osteonecrosis of jaw (242)
Dyspnoea (229)
Dizziness (224)
Diarrhoea (211)
Arthralgia (207)
Nausea (203)
Fatigue (193)
Pyrexia (179)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
Which IBANDRONIC ACID Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
IBANDRONIC ACID vs IBERDOMIDE
IBANDRONIC ACID vs IBREXAFUNGERP
IBANDRONIC ACID vs IBRITUMOMAB TIUXETAN
IBANDRONIC ACID vs IBRUTINIB
IBANDRONIC ACID vs IBUPROFEN